Diabetes
Feature
Novo rejects U.S. insulin price hikes report, has ‘nothing to hide’
The drugmaker has rejected allegations by a U.S. congressional investigative committee that it has engaged in maneuvers to increase net insulin...
From the Journals
Anxiety in men tied to risk factors for CVD, diabetes
Worry and neuroticism, both aspects of anxiety, when seen in midlife are associated with differences in risk for heart disease and diabetes that...
Latest News
AHA annual stats update highlights heart-brain connection
“The global rate of brain disease is quickly outpacing heart disease.”
News
FDA okays first tubing-free ‘artificial pancreas’ Omnipod 5
The system automatically adjusts insulin levels based on individual settings and predictive technology.
News
More than 1 in 10 people in U.S. have diabetes, CDC says
According to the latest National Diabetes Statistics Report, a quarter of those with diabetes are undiagnosed and over a third of the U.S....
From the Journals
Moderate-vigorous stepping seen to lower diabetes risk in older women
More steps per day, particularly at a higher intensity, may reduce the risk of type 2 diabetes in older women, based on a prospective cohort study...
News
Medtronic recalls HawkOne directional atherectomy system
The Class I recall warns that the system’s catheter tip may break off or separate during use, which could lead to serious adverse events.
Feature
‘We just have to keep them alive’: Transitioning youth with type 1 diabetes
Transitioning a teen with type 1 diabetes from pediatric care to taking full responsibility for their own condition under an adult team is one of...
From the Journals
‘Artificial pancreas’ life-changing in kids with type 1 diabetes
A semi-automated insulin delivery system using proprietary software improved time in target blood glucose range in young children aged 5 years, on...
From the Journals
Program targets preschoolers to promote heart health
A validated pilot program to educate preschoolers about heart health serves as a template for expanding the program into more schools.
From the Journals
Semaglutide tops sibling liraglutide for weight loss
A study showing that once-weekly subcutaneous semaglutide 2.4 mg (Wegovy, Novo Nordisk) produces greater long-term weight loss than once-daily...